Jove
Visualize
Contact Us

Related Experiment Videos

[A new surgical lavage].

H U Bühler, S t Mikic, O Wicki

    Helvetica Chirurgica Acta
    |May 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    This study investigated Taurolin, a novel surgical agent, for treating purulent peritonitis. Results show Taurolin effectively eliminated intraperitoneal bacteria in patients with peritonitis, with no significant adverse reactions observed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Hydroxylapatite-coated total prosthesis of the hip].

    Helvetica chirurgica acta·1990
    Same author

    [A new instrument for bone chip and spongiosa-plasty].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·1988
    Same author

    [Treatment of osteomyelitis with resorbable, antiseptic gel].

    Helvetica chirurgica acta·1983
    Same author

    [Therapy of purulent peritonitis. Documentation of 78 cases and experience with taurolin (author's transl)].

    Langenbecks Archiv fur Chirurgie·1981
    Same author

    [Intravenous and intraperitoneal administration of an antiseptic: 65 cases of diffuse peritonitis treated with taurolin].

    Helvetica chirurgica acta·1980
    Same author

    [Tauroline in peritonitis].

    Aktuelle Probleme in Chirurgie und Orthopadie·1979
    Same journal

    Carotid tumor and carotid sinus syndrome.

    Helvetica chirurgica acta·2010
    Same journal

    About causalgia.

    Helvetica chirurgica acta·2010
    Same journal

    Severe post-traumatic disorder of the upper limb; section of the 2nd thoracic node; healing.

    Helvetica chirurgica acta·2010
    Same journal

    The Cottes operation (resection of the presacral nerve) as an occasional operation for chronic appendicitis and severe dysmenorrhea.

    Helvetica chirurgica acta·2010
    Same journal

    Stone cast of the kidney pelvis; giant sarcoma of the mom.

    Helvetica chirurgica acta·2010
    Same journal

    For the plastic restoration of the female urethra.

    Helvetica chirurgica acta·2010
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Surgical innovation
    • Microbiology
    • Pharmacology

    Context:

    • Purulent peritonitis presents a significant clinical challenge.
    • Gram-negative sepsis and endotoxin denaturation are critical concerns in intra-abdominal infections.
    • Novel antimicrobial agents are needed for surgical site infections.

    Purpose:

    • To evaluate the efficacy and safety of Taurolin as a surgical lavaging and instillation agent in patients with purulent peritonitis.
    • To assess the bactericidal and endotoxin-denaturing properties of Taurolin in vivo.
    • To determine the impact of Taurolin on intraperitoneal bacterial load.

    Summary:

    • A novel non-toxic formaldehyde-transmitter, Taurolin, with a Thiadiazine structure was used in the surgical treatment of 62 patients with appendicitis and peritonitis.

    Related Experiment Videos

  • 0.5% Taurolin was employed for lavaging and 2% Taurolin for instillation.
  • Within 5 days, 22 of 25 patients with purulent peritonitis achieved bacterial clearance from the peritoneal cavity.

    • Impact:

    • Taurolin demonstrates significant bactericidal activity against Gram-negative bacteria.
    • The agent effectively denatures endotoxins in vivo, mitigating sepsis complications.
    • The study suggests Taurolin is a safe and effective adjunct in managing purulent peritonitis, with no observed adverse drug reactions.